About ONCOHOST
ONCOHOST is a company founded in 2017 by Yuval Shaked and Ofer Sharon.. ONCOHOST has raised $43 million across 4 funding rounds from investors including OurCrowd, European Commission and Menorah Mivathim. ONCOHOST offers products and services including PROphet Platform and PROphetNSCLC Test. ONCOHOST operates in a competitive market with competitors including Oncimmune, Biodesix, OncoCyte, GenomOncology and Broncus, among others.
- Founders Yuval Shaked, Ofer Sharon
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$43 M (USD)
in 4 rounds
-
Latest Funding Round
$2.8 M (USD), Grant
May 15, 2025
-
Investors
OurCrowd
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ONCOHOST
ONCOHOST offers a comprehensive portfolio of products and services, including PROphet Platform and PROphetNSCLC Test. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI platform for predicting benefits of cancer therapies using proteomics
Specific test for non-small cell lung cancer treatment predictions
Unlock access to complete
Unlock access to complete
Funding Insights of ONCOHOST
ONCOHOST has successfully raised a total of $43M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $2.8 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $2.8M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2025 | Amount | Grant - ONCOHOST | Valuation |
investors |
|
| May, 2022 | Amount | Series C - ONCOHOST | Valuation | ALIVE | |
| Jan, 2021 | Amount | Series B - ONCOHOST | Valuation | OurCrowd |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ONCOHOST
ONCOHOST has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include OurCrowd, European Commission and Menorah Mivathim. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Investment banking and advisory services are provided by Leumi Partners.
|
Founded Year | Domain | Location | |
|
Pension and provident funds are managed by Israeli non-banking institution.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ONCOHOST
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ONCOHOST
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oncohost Comparisons
Competitors of ONCOHOST
ONCOHOST operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oncimmune, Biodesix, OncoCyte, GenomOncology and Broncus, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Diagnostics and risk assessment solutions for lung cancer are developed.
|
|
| domain | founded_year | HQ Location |
Cancer detection diagnostics assays are developed and offered.
|
|
| domain | founded_year | HQ Location |
Non-invasive diagnostic test solutions for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Genomic data is transformed into actionable insights for precision medicine.
|
|
| domain | founded_year | HQ Location |
Minimally invasive technologies for lung disease treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Oncohost
Frequently Asked Questions about ONCOHOST
When was ONCOHOST founded?
ONCOHOST was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Who is the current CEO of ONCOHOST?
Ofer Sharon is the current CEO of ONCOHOST. They have also founded this company.
Is ONCOHOST a funded company?
ONCOHOST is a funded company, having raised a total of $43M across 4 funding rounds to date. The company's 1st funding round was a Series B of $8M, raised on Jan 21, 2020.
What does ONCOHOST do?
ONCOHOST was founded in 2017 as a provider of AI-based solutions in the oncology sector. Proteomic changes in blood samples are analyzed to evaluate patient responses to cancer therapies. Treatment strategies are recommended to enhance therapy effectiveness. Consultancy services are delivered to patients, oncologists, nurses, and pharmaceutical companies. The PROphet bioinformatics tool is employed to detect proteomic patterns associated with therapy outcomes.
Who are the top competitors of ONCOHOST?
ONCOHOST's top competitors include Biodesix, OncoCyte and GenomOncology.
What products or services does ONCOHOST offer?
ONCOHOST offers PROphet Platform and PROphetNSCLC Test.
Who are ONCOHOST's investors?
ONCOHOST has 6 investors. Key investors include OurCrowd, European Commission, Menorah Mivathim, ALIVE, and Leumi Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.